CareDx (CDNA)
(Real Time Quote from BATS)
$28.33 USD
-1.30 (-4.39%)
Updated Sep 23, 2024 12:32 PM ET
2-Buy of 5 2
F Value A Growth F Momentum C VGM
Brokerage Reports
CareDx, Inc. [CDNA]
Reports for Purchase
Showing records 1 - 20 ( 83 total )
Company: CareDx, Inc.
Industry: Medical Services
Solid Financial Performance in 2Q24; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Patent Dispute Has No Impact on Patient Access; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
1Q24 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
2023 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Positive Trend in Organ Donation; Patent Litigation Update; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Optimized Entry and Exit Levels for CDNA 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: CareDx, Inc.
Industry: Medical Services
Test Volume Stabilizes in 3Q23; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
MolDX Revised Billing Article In Dispute; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
2Q23 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
AlloSure Lung Receives Medicare Coverage; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
1Q23 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
MolDX Revises Coverage For Solid Organ Transplantation Tests; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Full-Year 2022 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Latest Advancements in Cellular Therapy Monitoring To Be Showcased; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Published Guide Advocates Use of Noninvasive Surveillance for Heart Transplant; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
Preliminary 2022 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
New Guidelines Support Earlier and Routine Use of HeartCare Tests; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
3Q22 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
2Q22 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: CareDx, Inc.
Industry: Medical Services
1Q22 Financial Results Reported; Reiterate Neutral
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y